Who Is — And Will Be — Making Money From COVID-19 Vaccines?
Schroders' Expert John Bowler Analyzes The Pharmaceutical Groups Involved In COVID-19 Drug Development, Emphasizing That Their Efforts Will Be Rewarded In The Future, Despite Current Low Benefits.